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Patel’s jaunty and amusing article concludes with: “after all,
how bad can man flu be?”1 The answer is that, for men and
women, flu can be devastating and even lethal. This is especially
true for sick and vulnerable patients. Patel misses the point: we
should be vaccinated not only to keep us hard at work through
those long winter days and nights, but also to prevent us getting
flu and, despite feeling lousy, struggling in to work and infecting
our patients. Doctors cannot rely on recollection of symptoms
to knowwhether they have been infected or are protected against
flu.2
In our study of 1520 patients with flu in 75 different NHS
hospitals during the 2009 pandemic, we identified 30 cases of
probable hospital acquired infection. Of these, 26 had serious
underlying illnesses. Only 12 were treated with appropriate
antiviral drugs within 48 hours of onset, more than half needed
escalated care, and eight died.3 Although we do not know how
many were infected by hospital staff, these findings clearly
support this autumn’s campaign to boost our patchy record on
healthcare worker vaccination.
The arguments are not only scientific but moral. We all know
that a precept of medical ethics is “first, do no harm,” and the
GeneralMedical Council clearly advises us to conduct ourselves
in a manner that minimises the harmwe do to those in our care.4
Patel is wrong to focus on his personal freedom, seeming to
ignore the potential consequences of his choices on the health
and survival of his patients.
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